Myocardial autophagy was decreased after nonlethal mechanism trauma. by Jie Wang (16762)

Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

“…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”

Procedure related data, LBNP, LBPP and hypoxia. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

Individual biometric data of patients. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

miR-145 decreases glioma cell migration. by Hae Kyung Lee (285269)

Decreased energy intake in Het GIP Tg mice. by Su-Jin Kim (90561)

RNA interference-mediated decrease in Ixofin3D results in decreased <i>B. burgdorferi</i> burden in the salivary glands and in murine skin. by Sukanya Narasimhan (73432)

EGCG decreases RSK2-mediated cell viability. by Hanyong Chen (320863)

“…RSK2^+/+ and RSK2^-/- MEFs (5 X 10³) were seeded, cultured overnight, and then treated with 10 μM EGCG. …”

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

ANG II treatment leads to decreased contractile function. by Renita E. Horton (847891)

“…(E) Representative stress traces generated from x-projections of films (F) ANG II treatment leads to a decrease in contractile stress generation. Control n = 85 tissues, 5 nM n = 15 tissues, 100 nM n = 69 tissues, 3 harvests. …”

Decreased Klotho expression in kidneys from hyperlipidemic mice. by Cristina Sastre (503532)

<i>son</i> reduction decreases T cell numbers. by Rebecca L. Belmonte (8384103)

Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4‑<i>b</i>]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Assoc... by Mary A. Foutz (20361830)

“…Pharmacokinetic studies indicated a half-life of 2 h, <i>C</i>_max of 35 μM, and no observed adverse effects at 1,000 mg kg^–1 dose in mice. In a Gubra-Amylin (GAN) mouse model of MASH, <b>SHO1122147</b> was efficacious in decreasing body weight and liver triglyceride levels at 200 mg kg^–1 day^–1 without changes in body temperature. …”

<i>ism1</i> knockdown decreases erythrocytes. by Arturo Berrun (5216003)

Promoter activities of DNA-DRR genes decreased with DEC. by Hideaki Nakamura (402108)

Bone mass and formation are decreased in Akt1-/- mice. by Naohiro Kawamura (33999)

Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

“…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”

Inhibition of Hh signaling decreases hMSC proliferation. by Magali Plaisant (230886)

Decreased β-cell mass in Hq mutant mice. by Fabienne T. Schulthess (13268705)

CHIP overexpression decreases α-syn oligomer levels. by Lorraine V. Kalia (355943)